bullish

Jiangsu Hengrui Medicine (600276.CH) - About The Performance Recovery and the Concerns Behind

483 Views04 Jan 2023 08:55
Hengrui's low point was in 2022.Performance will gradually recover due to the ease of negative policy impact.But share price's hard to generate excess return due to concerns on business transformation
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
x